ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693547 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693547; 2) Community: the network communities that were significantly associated with the response to NSC 693547; 3) Molecule: the relationships between components within communities and NSC 693547; 4) MDR: the compounds that were significantly associated with the NSC 693547.

NSC Compound Enrichment Correlation
NSC 689529 Null 0.00322389497932883 0.33272426
NSC 726899 Null 0.00322389497932885 0.42768112
NSC 750721 10-(3,4-dimethoxyphenyl)-6-(2-hydroxyethyl)-2,3,7,10-tetrahydro-[1,4]dioxino[2,3-g]furo[3,4-b]quinolin-9(6H)-one 0.00322389497932885 0.44301374
NSC 174121 Methotrexate Derivative 0.0038671642008129 0.34462982
NSC 271674 Carboxyphthalatoplatinum 0.0038671642008129 0.48161233
NSC 625497 Antimony, dibromo(4-thiomorpholinecarbodithioato-S,S')-, (T-4)- 0.0038671642008129 0.50483801
NSC 647638 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) 0.0038671642008129 0.1062711
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.0038671642008129 0.33528775
NSC 740252 Null 0.00386716420081295 0.38885586
NSC 268242 N,N-Dibenzyldaunorubicin 0.00423163567577548 0.54632003
Total:147  Current:22    [First] [Prev] [Next] [Last]